MetaVia Inc. SEC filings MTVA
MetaVia Inc. has 633 filings in SEC EDGAR's recent list, going back to Apr 8, 2015. Its latest annual report, Form ARS, was filed on Apr 27, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (regulation fd disclosure, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| ARS | Annual report to shareholders | Apr 27, 2026 | Dec 31, 2025 |
| 10-K | Annual report | Mar 26, 2026 | Dec 31, 2025 |
| ARS | Annual report to shareholders | Jun 10, 2025 | Dec 31, 2024 |
| 10-K | Annual report | Mar 20, 2025 | Dec 31, 2024 |
| ARS | Annual report to shareholders | Apr 30, 2024 | Dec 31, 2023 |
| 10-K | Annual report | Mar 28, 2024 | Dec 31, 2023 |
| ARS | Annual report to shareholders | May 26, 2023 | Dec 31, 2022 |
| 10-K | Annual report | Mar 30, 2023 | Dec 31, 2022 |
| 10-K | Annual report | Mar 31, 2022 | Dec 31, 2021 |
| 10-K/A | Amended annual report | Apr 30, 2021 | Dec 31, 2020 |
| 10-K | Annual report | Apr 15, 2021 | Dec 31, 2020 |
| 10-K | Annual report | Mar 30, 2020 | Dec 31, 2019 |
| 10-K | Annual report | Mar 18, 2019 | Dec 31, 2018 |
| 10-K/A | Amended annual report | Aug 22, 2018 | Dec 31, 2017 |
| 10-K | Annual report | Mar 20, 2018 | Dec 31, 2017 |
| 10-K | Annual report | Mar 21, 2017 | Dec 31, 2016 |
Showing 16 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- MTVA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Cambridge, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1638287
- Former names
- NeuroBo Pharmaceuticals, Inc. (until Nov 18, 2024); Gemphire Therapeutics Inc. (until Dec 31, 2019)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.